低分子注射薬の世界市場レポート 2025年

低分子注射薬市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.6％で3,996億7,000万米ドルに成長します。予測期間の成長は、個別化ヘルスケア、デジタルヘルス統合、サプライチェーン最適化、実環境エビデンス活用、外来医療へのシフトに起因すると考えられます。予測期間の主な動向には、ドラッグデリバリーシステムの進歩、技術の進歩、研究開発の注力、注射療法の革新、新薬製剤の迅速な承認などが含まれます。

慢性疾患の有病率の高まりは、当面、低分子注射剤市場の大きな成長を牽引すると予想されます。慢性疾患は、長引く持続性と緩やかな進行を特徴とし、座りがちなライフスタイル、不健康な食習慣、タバコの使用、ストレスレベルの上昇などの要因によって増加傾向にあります。このようなライフスタイルの選択は、肥満、糖尿病、心血管疾患、特定のがんなどの疾患の発生に寄与しています。低分子注射剤は、標的治療、コンプライアンス強化、疾患修飾、併用療法オプション、治療モニタリングの機会を提供することにより、慢性疾患の管理において極めて重要な役割を果たしています。例えば、2023年9月の世界保健機関（WHO）のデータによると、非感染性疾患（NCDs）または慢性疾患は、世界の年間死亡者数4,100万人の74％を占めています。このうち1,790万人が心血管疾患、930万人ががん、410万人が慢性呼吸器疾患、200万人が糖尿病によるもので、低分子注射剤市場の成長の原動力となっています。

低分子注射剤市場に参入している企業は、経口薬に含まれる有効成分の溶解性を高めるため、微粒子技術などの新技術の開発に注力しています。マイクロパーティクル技術は、ポリマー、金属、セラミックス、複合材料など様々な材料を用いて、通常ナノメートルからマイクロメートルの大きさのマイクロスケールレベルの粒子を設計、製造、応用するものです。例えば、2022年3月、ドイツを拠点とする特殊化学品メーカーであるエボニック・インダストリーズ社は、経口医薬品における医薬品有効成分の溶解性向上を目的とした新規の微粒子技術であるEUDRATEC SoluFlowを発表しました。この革新的なエマルジョンベースのプロセス技術は、従来の製造方法が直面していた溶解性の課題、特に化合物の70％以上が不溶性である新規低分子治療薬の課題に対処するものです。EUDRATECのSoluFlowは、難溶性薬剤を非晶質固体分散体（ASD）の流動性のある粉末に変換することにより、がん、心血管疾患、感染症、糖尿病を含む様々な治療分野における新規経口治療薬の開発を促進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の低分子注射薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の低分子注射薬市場：成長率分析
• 世界の低分子注射薬市場の実績：規模と成長、2019年～2024年
• 世界の低分子注射薬市場の予測：規模と成長、2024年～2029年、2034年
• 世界の低分子注射薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の低分子注射薬市場：薬剤クラス別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 低分子抗生物質
• 鎮痛剤
• 化学療法
• 抗ウイルス薬
• 抗凝固剤
• 骨格筋弛緩薬
• 抗けいれん薬
• その他の薬物クラス
• 世界の低分子注射薬市場：適応症別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 疼痛管理
• 腫瘍学
• 感染症
• 心血管疾患
• 中枢神経疾患
• その他の適応症
• 世界の低分子注射薬市場：配送方法別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 点滴セット
• 静脈注射
• 輸液ポンプ
• 筋肉内注射
• 皮下注射
• 世界の低分子注射薬市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• 外来診療所
• 外来施設
• 輸液療法センター
• ホームケア
• その他のエンドユーザー
• 世界の低分子注射薬市場、低分子抗生物質タイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ペニシリン系抗生物質
• セファロスポリン
• アミノグリコシド
• マクロライド
• テトラサイクリン
• 世界の低分子注射薬市場、鎮痛剤タイプ別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 非ステロイド性抗炎症薬（NSAID）
• オピオイド
• アセトアミノフェン
• 世界の低分子注射薬市場、化学療法タイプ別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• アルキル化剤
• 代謝拮抗物質
• 有糸分裂阻害剤
• トポイソメラーゼ阻害剤
• 世界の低分子注射薬市場、抗ウイルス薬タイプ別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ヌクレオシド類似体
• プロテアーゼ阻害剤
• 逆転写酵素阻害剤
• 世界の低分子注射薬市場、抗凝固剤タイプ別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ヘパリン
• 低分子量ヘパリン
• 直接経口抗凝固薬（DOAC）
• 世界の低分子注射薬市場、骨格筋弛緩薬タイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• バクロフェン
• シクロベンザプリン
• メトカルバモール
• 世界の低分子注射薬市場、抗てんかん薬タイプ別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ベンゾジアゼピン
• フェニトイン
• カルバマゼピン
• 世界の低分子注射薬市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 免疫抑制剤
• 生物学的製剤
• ホルモン療法

第7章 地域別・国別分析

• 世界の低分子注射薬市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の低分子注射薬市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 低分子注射薬市場：競合情勢
• 低分子注射薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Becton Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• Baxter International Inc.
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 低分子注射薬市場2029年：新たな機会を提供する国
• 低分子注射薬市場2029年：新たな機会を提供するセグメント
• 低分子注射薬市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Small molecule injectable drugs refer to pharmaceutical substances characterized by their small size and low molecular weight. These medications are typically administered via injection, including intravenous, intramuscular, or subcutaneous routes, to ensure systemic distribution throughout the body.

The primary types of drug classes within small-molecule injectable drugs encompass small-molecule antibiotics, analgesics, chemotherapy agents, antivirals, anticoagulants, skeletal muscle relaxants, anticonvulsants, and others. Small-molecule antibiotics, for instance, are antibacterial medications featuring a low molecular weight and simple chemical structure. These drugs find applications across various medical indications such as pain management, oncology, infectious diseases, cardiovascular diseases, central nervous system (CNS) disorders, among others. Delivery of small-molecule injectable drugs encompasses various methods including IV sets, intravenous injections, infusion pumps, intramuscular injections, and subcutaneous injections. These delivery modalities cater to diverse end-users including hospitals, ambulatory clinics, outpatient facilities, infusion therapy centers, home care settings, and others.

The small molecule injectable drugs market research report is one of a series of new reports from The Business Research Company that provides small molecule injectable drugs market statistics, including small molecule injectable drugs industry global market size, regional shares, competitors with a small molecule injectable drugs market share, detailed small molecule injectable drugs market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule injectable drugs industry. This small-molecule injectable drug market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The small molecule injectable drugs market size has grown rapidly in recent years. It will grow from $219.57 billion in 2024 to $248.2 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to rising chronic diseases, aging population, government initiatives, increasing healthcare expenditure, improved manufacturing processes.

The small molecule injectable drugs market size is expected to see rapid growth in the next few years. It will grow to $399.67 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to personalized healthcare, digital health integration, supply chain optimization, real-world evidence utilization, shift towards outpatient care. Major trends in the forecast period include advancements in drug delivery systems, technological advancements, focus on research and development, innovation in injectable therapies, fast-track approvals of new drug formulation.

The escalating prevalence of chronic diseases is anticipated to drive significant growth in the small-molecule injectable drug market in the foreseeable future. Chronic diseases, characterized by prolonged persistence and gradual progression, are on the rise due to factors such as sedentary lifestyles, unhealthy dietary habits, tobacco use, and increasing stress levels. These lifestyle choices contribute to the emergence of conditions such as obesity, diabetes, cardiovascular diseases, and certain cancers. Small-molecule injectable drugs play a pivotal role in managing chronic diseases by providing targeted therapy, enhanced compliance, disease modification, combination therapy options, and opportunities for therapeutic monitoring. For instance, according to the World Health Organization's data in September 2023, non-communicable diseases (NCDs) or chronic diseases accounted for 74% of the 41 million global deaths annually. Among these, 17.9 million were due to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes, underscoring the driving force behind the growth of the small-molecule injectable drug market.

Companies operating in the small-molecule injectable drug market are concentrating on advancing new technologies, such as microparticle technology, to enhance the solubility of active pharmaceutical ingredients in oral drug products. Microparticle technology involves the design, fabrication, and application of particles at the microscale level, typically ranging from nanometers to micrometers in size, using various materials such as polymers, metals, ceramics, and composites. For example, in March 2022, Evonik Industries AG, a Germany-based specialty chemicals company, introduced EUDRATEC SoluFlow, a novel microparticle technology aimed at improving the solubility of active pharmaceutical ingredients in oral drug products. This innovative emulsion-based process technology addresses solubility challenges faced by traditional manufacturing methods, particularly for new small-molecule therapeutics where over 70% of compounds are insoluble. EUDRATEC SoluFlow facilitates the development of new oral therapeutics across various therapeutic areas, including cancer, cardiovascular diseases, infectious diseases, and diabetes, by converting poorly soluble drugs into free-flowing powders of amorphous solid dispersions (ASD).

In April 2023, Delpharm SAS, a France-based drug developer and contract manufacturer, acquired the Leiden Development Centre in the Netherlands from Dr. Reddy's Laboratories for an undisclosed sum. This acquisition supports Delpharm's strategy to expand its pharmaceutical development services, particularly in injectable formulations. Delpharm aims to offer a comprehensive "one-stop shop" service for clients seeking to develop injectable drugs, thereby accelerating the availability of new medicines for patients. Dr. Reddy's Laboratories, an India-based pharmaceutical company, has been providing small-molecule injectable drug formulations through the Leiden Development Centre.

Major companies operating in the small molecule injectable drugs market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, Fresenius Kabi AG, GlaxoSmithKline plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Baxter International Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals plc, BioCryst Pharmaceuticals Inc., Mylan N.V.

North America was the largest region in the small molecule injectable drugs market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small molecule injectable drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the small molecule injectable drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecule injectable drugs market consists of sales of antineoplastic agents, hormones, and vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule Injectable Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule injectable drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule injectable drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small molecule injectable drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Small Molecule Antibiotics; Analgesics; Chemotherapy; Antivirals; Anticoagulant; Skeletal Muscle Relaxants; Anticonvulsants; Other Drug Class
• 2) By Indication: Pain Management; Oncology; Infectious Diseases; Cardiovascular Diseases; CNS Diseases; Other Indications
• 3) By Mode of Delivery: IV Set; Intravenous Injection; Infusion Pump; Intramuscular Injection; Subcutaneous Injection
• 4) By End User: Hospitals; Ambulatory Clinics; Outpatient Facility; Infusion Therapy Center; Home Care; Other End Users
• Subsegments:
• 1) By Small Molecule Antibiotics: Penicillin-Based Antibiotics; Cephalosporins; Aminoglycosides; Macrolides; Tetracyclines
• 2) By Analgesics: Nonsteroidal Anti-inflammatory Drugs (NSAIDs); Opioids; Acetaminophen
• 3) By Chemotherapy: Alkylating Agents; Antimetabolites; Mitotic Inhibitors; Topoisomerase Inhibitors
• 4) By Antivirals: Nucleoside Analogues; Protease Inhibitors; Reverse Transcriptase Inhibitors
• 5) By Anticoagulant: Heparin; Low Molecular Weight Heparins; Direct Oral Anticoagulants (DOACs)
• 6) By Skeletal Muscle Relaxants: Baclofen; Cyclobenzaprine; Methocarbamol
• 7) By Anticonvulsants: Benzodiazepines; Phenytoin; Carbamazepine
• 8) By Other Drug Class: Immunosuppressants; Biologic Agents; Hormonal Therapies
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Molecule Injectable Drugs Market Characteristics

3. Small Molecule Injectable Drugs Market Trends And Strategies

4. Small Molecule Injectable Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Small Molecule Injectable Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Small Molecule Injectable Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Small Molecule Injectable Drugs Market Growth Rate Analysis
• 5.4. Global Small Molecule Injectable Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Small Molecule Injectable Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Small Molecule Injectable Drugs Total Addressable Market (TAM)

6. Small Molecule Injectable Drugs Market Segmentation

• 6.1. Global Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule Antibiotics
• Analgesics
• Chemotherapy
• Antivirals
• Anticoagulant
• Skeletal Muscle Relaxants
• Anticonvulsants
• Other Drug Class
• 6.2. Global Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• CNS Diseases
• Other Indications
• 6.3. Global Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Set
• Intravenous Injection
• Infusion Pump
• Intramuscular Injection
• Subcutaneous Injection
• 6.4. Global Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Clinics
• Outpatient Facility
• Infusion Therapy Center
• Home Care
• Other End Users
• 6.5. Global Small Molecule Injectable Drugs Market, Sub-Segmentation Of Small Molecule Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillin-Based Antibiotics
• Cephalosporins
• Aminoglycosides
• Macrolides
• Tetracyclines
• 6.6. Global Small Molecule Injectable Drugs Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Opioids
• Acetaminophen
• 6.7. Global Small Molecule Injectable Drugs Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkylating Agents
• Antimetabolites
• Mitotic Inhibitors
• Topoisomerase Inhibitors
• 6.8. Global Small Molecule Injectable Drugs Market, Sub-Segmentation Of Antivirals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleoside Analogues
• Protease Inhibitors
• Reverse Transcriptase Inhibitors
• 6.9. Global Small Molecule Injectable Drugs Market, Sub-Segmentation Of Anticoagulant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Heparin
• Low Molecular Weight Heparins
• Direct Oral Anticoagulants (DOACs)
• 6.10. Global Small Molecule Injectable Drugs Market, Sub-Segmentation Of Skeletal Muscle Relaxants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Baclofen
• Cyclobenzaprine
• Methocarbamol
• 6.11. Global Small Molecule Injectable Drugs Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Benzodiazepines
• Phenytoin
• Carbamazepine
• 6.12. Global Small Molecule Injectable Drugs Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunosuppressants
• Biologic Agents
• Hormonal Therapies

7. Small Molecule Injectable Drugs Market Regional And Country Analysis

• 7.1. Global Small Molecule Injectable Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Small Molecule Injectable Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Molecule Injectable Drugs Market

• 8.1. Asia-Pacific Small Molecule Injectable Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Molecule Injectable Drugs Market

• 9.1. China Small Molecule Injectable Drugs Market Overview
• 9.2. China Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Molecule Injectable Drugs Market

• 10.1. India Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Molecule Injectable Drugs Market

• 11.1. Japan Small Molecule Injectable Drugs Market Overview
• 11.2. Japan Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Molecule Injectable Drugs Market

• 12.1. Australia Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Molecule Injectable Drugs Market

• 13.1. Indonesia Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Molecule Injectable Drugs Market

• 14.1. South Korea Small Molecule Injectable Drugs Market Overview
• 14.2. South Korea Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Molecule Injectable Drugs Market

• 15.1. Western Europe Small Molecule Injectable Drugs Market Overview
• 15.2. Western Europe Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Molecule Injectable Drugs Market

• 16.1. UK Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Molecule Injectable Drugs Market

• 17.1. Germany Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Molecule Injectable Drugs Market

• 18.1. France Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Molecule Injectable Drugs Market

• 19.1. Italy Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Molecule Injectable Drugs Market

• 20.1. Spain Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Molecule Injectable Drugs Market

• 21.1. Eastern Europe Small Molecule Injectable Drugs Market Overview
• 21.2. Eastern Europe Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Molecule Injectable Drugs Market

• 22.1. Russia Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Molecule Injectable Drugs Market

• 23.1. North America Small Molecule Injectable Drugs Market Overview
• 23.2. North America Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Molecule Injectable Drugs Market

• 24.1. USA Small Molecule Injectable Drugs Market Overview
• 24.2. USA Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Molecule Injectable Drugs Market

• 25.1. Canada Small Molecule Injectable Drugs Market Overview
• 25.2. Canada Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Molecule Injectable Drugs Market

• 26.1. South America Small Molecule Injectable Drugs Market Overview
• 26.2. South America Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Molecule Injectable Drugs Market

• 27.1. Brazil Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Molecule Injectable Drugs Market

• 28.1. Middle East Small Molecule Injectable Drugs Market Overview
• 28.2. Middle East Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Molecule Injectable Drugs Market

• 29.1. Africa Small Molecule Injectable Drugs Market Overview
• 29.2. Africa Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Molecule Injectable Drugs Market Competitive Landscape And Company Profiles

• 30.1. Small Molecule Injectable Drugs Market Competitive Landscape
• 30.2. Small Molecule Injectable Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Small Molecule Injectable Drugs Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Abbott Laboratories
• 31.5. Novartis AG
• 31.6. Fresenius Kabi AG
• 31.7. GlaxoSmithKline plc
• 31.8. Eli Lilly and Company
• 31.9. Gilead Sciences Inc.
• 31.10. Amgen Inc.
• 31.11. Becton Dickinson and Company
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. Baxter International Inc.
• 31.14. Sun Pharmaceutical Industries Ltd.
• 31.15. Aurobindo Pharma Ltd.

32. Global Small Molecule Injectable Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Molecule Injectable Drugs Market

34. Recent Developments In The Small Molecule Injectable Drugs Market

35. Small Molecule Injectable Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Small Molecule Injectable Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Small Molecule Injectable Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Small Molecule Injectable Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer